Sector
Healthcare Insider Trading Activity
Every SEC Form 4 insider transaction reported by Healthcare companies — biotech, pharmaceuticals, medical devices, and providers — sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are Healthcare insiders buying or selling?
Healthcare insiders reported 18,416 open-market buys ($40.5B) and 62,224 sells ($212.9B) across 80,640 Form 4 filings from 1,244 companies — a net selling position of $172.4B.
Source: SEC EDGAR Form 4
Key Statistics (as of Oct 17, 2026)
Total Form 4 filings
80,640
SEC EDGAR
Companies
1,244
Insider buys (18,416)
$40.5B
Insider sells (62,224)
$212.9B
Sector sentiment
Net sellingNet insider flow of $172.4B in net selling across 10,687 insider filers.
Most active Healthcare companies
| # | Company | Form 4 filings |
|---|---|---|
| 1 | MRNAModerna, Inc. | 826 |
| 2 | NTRANatera, Inc. | 729 |
| 3 | UTHRUNITED THERAPEUTICS Corp | 701 |
| 4 | BLFSBIOLIFE SOLUTIONS INC | 685 |
| 5 | VRTXVERTEX PHARMACEUTICALS INC / MA | 575 |
| 6 | EWEdwards Lifesciences Corp | 526 |
| 7 | TWSTTwist Bioscience Corp | 518 |
| 8 | DXCMDEXCOM INC | 505 |
| 9 | TDOCTeladoc Health, Inc. | 481 |
| 10 | RVPRETRACTABLE TECHNOLOGIES INC | 444 |
| 11 | RMDRESMED INC | 433 |
| 12 | CYTKCYTOKINETICS INC | 419 |
| 13 | PGNYProgyny, Inc. | 402 |
| 14 | ADPTAdaptive Biotechnologies Corp | 397 |
| 15 | NBIXNEUROCRINE BIOSCIENCES INC | 392 |
| 16 | LLYELI LILLY & Co | 387 |
| 17 | VEEVVEEVA SYSTEMS INC | 383 |
| 18 | CSTLCASTLE BIOSCIENCES INC | 379 |
| 19 | APLSApellis Pharmaceuticals, Inc. | 366 |
| 20 | DNAGinkgo Bioworks Holdings, Inc. | 361 |
| 21 | PHRPhreesia, Inc. | 357 |
| 22 | REGNREGENERON PHARMACEUTICALS, INC. | 354 |
| 23 | NVCRNovoCure Ltd | 351 |
| 24 | BSXBOSTON SCIENTIFIC CORP | 348 |
| 25 | SIBNSI-BONE, Inc. | 337 |
Recent Healthcare insider transactions
| Date | Ticker | Insider | Type | Value | Filing |
|---|---|---|---|---|---|
| Oct 17, 2026 | NTRA | Matthew RabinowitzEXECUTIVE CHAIRMAN | Sale | $20.1M | SEC ↗ |
| Oct 17, 2026 | GRCE | Opaleye Management Inc.10% Owner | Purchase | $136.2K | SEC ↗ |
| Oct 17, 2026 | BEAM | John M. EvansCEO | Sale | $1.2M | SEC ↗ |
| Oct 16, 2026 | CTMX | Sean A. MccarthyCEO | Sale | $461.9K | SEC ↗ |
| Oct 16, 2026 | ADPT | Julie RubinsteinPresident and COO | Sale | $897.4K | SEC ↗ |
| Oct 16, 2026 | BLLN | Oguzhan AtayChairman and CEO | Sale | $1.1M | SEC ↗ |
| Oct 16, 2026 | ANIP | Nikhil LalwaniPRESIDENT & CEO | Sale | $388.2K | SEC ↗ |
| Oct 16, 2026 | DOCS | Siddharth SitaramChief Accounting Officer | Sale | $80.2K | SEC ↗ |
| Oct 16, 2026 | CORT | James N WilsonDirector | Sale | $1.1M | SEC ↗ |
| Oct 16, 2026 | MDT | Michael MarinaroEVP, Pres MedSurg and Americas | Sale | $1.0M | SEC ↗ |
| Oct 16, 2026 | PACS | Joshua JergensenPresident & COO | Sale | $1.8M | SEC ↗ |
| Oct 16, 2026 | MDT | Geoffrey MarthaChairman and CEO | Sale | $4.8M | SEC ↗ |
| Oct 16, 2026 | PACS | Jason Hulse MurrayCo-Founder, CEO & Chairman | Sale | $5.6M | SEC ↗ |
| Oct 16, 2026 | CRSP | Simeon GeorgeDirector | Sale | $720.4K | SEC ↗ |
| Oct 16, 2026 | PTCT | Michael SchmertzlerDirector | Sale | $149.0K | SEC ↗ |
| Oct 16, 2026 | MPLT | Anatol KreitzerChief Discovery Officer | Sale | $96.0K | SEC ↗ |
| Oct 16, 2026 | MPLT | Jonathan GillisCAO and Interim CFO | Sale | $82.1K | SEC ↗ |
| Oct 16, 2026 | MPLT | James Woodruff LillieChief Scientific Officer | Sale | $93.0K | SEC ↗ |
| Oct 16, 2026 | MPLT | Kristopher HansonGeneral Counsel | Sale | $72.9K | SEC ↗ |
| Oct 16, 2026 | MPLT | Erin Pennock FoffChief Medical Officer | Sale | $124.1K | SEC ↗ |
Showing the 20 most recent filings. Screen every Healthcare filing.
Healthcare insider trading FAQ
Are Healthcare insiders buying or selling?
Across 80,640 SEC Form 4 filings in the Healthcare sector, insiders reported 18,416 open-market purchases totaling $40.5B and 62,224 sales totaling $212.9B. That is a net selling position of $172.4B.
Which Healthcare companies have the most insider activity?
Moderna, Inc. (MRNA), Natera, Inc. (NTRA), UNITED THERAPEUTICS Corp (UTHR), BIOLIFE SOLUTIONS INC (BLFS), VERTEX PHARMACEUTICALS INC / MA (VRTX) lead the Healthcare sector by Form 4 filing count.
How many companies file Form 4s in the Healthcare sector?
1,244 Healthcare companies have reported SEC Form 4 insider transactions on Trabud, from 10,687 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly.
Where does Trabud get Healthcare insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Screen every Healthcare insider filing
Filter all 80,640 Healthcare Form 4 filings by transaction value, insider role, market cap, and date — or ask Trabud's AI agent in plain English.
Open the Healthcare screener